Jeremy Cole

1.9k total citations
19 papers, 277 citations indexed

About

Jeremy Cole is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Jeremy Cole has authored 19 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in Jeremy Cole's work include Asthma and respiratory diseases (12 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Respiratory and Cough-Related Research (5 papers). Jeremy Cole is often cited by papers focused on Asthma and respiratory diseases (12 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Respiratory and Cough-Related Research (5 papers). Jeremy Cole collaborates with scholars based in United States, France and Sweden. Jeremy Cole's co-authors include Giuseppe Micieli, A Prusiński, I. Monstad, Alison Pilgrim, Anya Hammann‐Haenni, Philippe Saudan, Ekkehard Beck, Cheryl Lassen, Jörg Willers and Thomas B. Casale and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Medical Physics.

In The Last Decade

Jeremy Cole

19 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeremy Cole United States 8 174 85 65 56 46 19 277
Jorunn Bratlie Norway 8 79 0.5× 51 0.6× 35 0.5× 19 0.3× 18 0.4× 10 408
Kuniaki Hirai Japan 8 184 1.1× 97 1.1× 5 0.1× 2 0.0× 27 0.6× 20 264
Naeimeh Hosseini Iran 6 63 0.4× 43 0.5× 4 0.1× 24 0.4× 39 0.8× 14 182
D. Duda Germany 9 43 0.2× 26 0.3× 13 0.2× 4 0.1× 34 0.7× 28 280
Hanne H. Villesen Denmark 9 365 2.1× 112 1.3× 4 0.1× 4 0.1× 13 0.3× 14 470
Leandro Genehr Fritscher Brazil 11 225 1.3× 188 2.2× 3 0.0× 4 0.1× 15 0.3× 20 426
G K Crompton United Kingdom 9 345 2.0× 292 3.4× 2 0.0× 5 0.1× 47 1.0× 17 450
Hansjosef Boehles Germany 9 42 0.2× 36 0.4× 7 0.1× 21 0.4× 14 0.3× 17 277
César Villarán United States 9 410 2.4× 356 4.2× 4 0.1× 2 0.0× 21 0.5× 11 462
Abdel M. Fuenmayor Venezuela 11 31 0.2× 21 0.2× 20 0.3× 5 0.1× 18 0.4× 32 456

Countries citing papers authored by Jeremy Cole

Since Specialization
Citations

This map shows the geographic impact of Jeremy Cole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Cole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Cole more than expected).

Fields of papers citing papers by Jeremy Cole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Cole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Cole. The network helps show where Jeremy Cole may publish in the future.

Co-authorship network of co-authors of Jeremy Cole

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Cole. A scholar is included among the top collaborators of Jeremy Cole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Cole. Jeremy Cole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Máspero, Jorge, Shirin Shafazand, Jeremy Cole, et al.. (2023). Dupilumab efficacy in high sleep disturbance management among patients with type 2 asthma. Respiratory Medicine. 218. 107344–107344. 2 indexed citations
3.
Fiocchi, Alessandro, Wanda Phipatanakul, Robert S. Zeiger, et al.. (2023). Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study. European Respiratory Journal. 62(5). 2300558–2300558. 18 indexed citations
4.
Hughes, Jason, et al.. (2022). Military Uniform Identification for Search And Rescue (SAR) through Machine Learning. 1–4. 2 indexed citations
5.
Fiocchi, Alessandro, Wanda Phipatanakul, Sandy Durrani, et al.. (2022). Dupilumab Improves Asthma Control, and Allergic Rhinitis-Related Health-Related Quality of Life in Children With Uncontrolled Persistent Asthma With Comorbid Allergic Rhinitis. Journal of Allergy and Clinical Immunology. 149(2). AB135–AB135. 1 indexed citations
6.
Fiocchi, Alessandro, Wanda Phipatanakul, Sandy Durrani, et al.. (2021). Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma. Ghent University Academic Bibliography (Ghent University). PA3920–PA3920. 1 indexed citations
7.
Cole, Jeremy, et al.. (2020). Surprisal Predicts Code-Switching in Chinese-English Bilingual Text. 4029–4039. 3 indexed citations
8.
Ferguson, Gary T., et al.. (2019). <p>Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results</p>. Journal of Asthma and Allergy. Volume 12. 363–373. 16 indexed citations
9.
Barker, Peter, et al.. (2019). Single-Use Autoinjector Functionality and Reliability for At-Home Benralizumab Administration: GRECO Trial Results. Journal of Allergy and Clinical Immunology. 143(2). AB96–AB96. 6 indexed citations
10.
Zeitlin, Pamela L., Mila A. Leong, Jeremy Cole, et al.. (2018). Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial. Journal of Asthma and Allergy. Volume 11. 181–192. 28 indexed citations
11.
Zeitlin, Pamela L., Mila A. Leong, Jeremy Cole, et al.. (2018). No Effect of Benralizumab Treatment on Antibody Response to Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Moderate to Severe Asthma: Results From the Phase IIIb ALIZE Trial. Journal of Allergy and Clinical Immunology. 141(2). AB14–AB14. 1 indexed citations
13.
Casale, Thomas B., Jeremy Cole, Ekkehard Beck, et al.. (2015). CYT003, a TLR9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study. Allergy. 70(9). 1160–1168. 55 indexed citations
14.
Wenzel, Sally E., Robert W. Hopkins, Michael D. Saunders, et al.. (2014). Safety and Efficacy Of ARRY-502, a Potent, Selective, Oral CRTh2 Antagonist, In Patients With Mild To Moderate Th2-Driven Asthma. Journal of Allergy and Clinical Immunology. 133(2). AB4–AB4. 14 indexed citations
16.
Allen, Ann, Isabelle Schenkenberger, Roopa Trivedi, et al.. (2013). Inhaled fluticasone furoate/vilanterol does not affect hypothalamic‐pituitary‐adrenal axis function in adolescent and adult asthma: randomised, double‐blind, placebo‐controlled study. The Clinical Respiratory Journal. 7(4). 397–406. 32 indexed citations
17.
18.
Monstad, I., et al.. (1995). Preemptive Oral Treatment With Sumatriptan During a Cluster Period. Headache The Journal of Head and Face Pain. 35(10). 607–613. 69 indexed citations
19.
Cole, Jeremy, Leslie M. Klevay, & Mitchell R. Zavon. (1970). Endrin and dieldrin: A comparison of hepatic excretion in the rat. Toxicology and Applied Pharmacology. 16(2). 547–555. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026